Stay updated on Pembrolizumab for Advanced Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2 on the page.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page.SummaryDifference0.1%

- Check54 days agoChange DetectedGlossary toggle controls were added (Show glossary / Hide glossary) and the footer now includes a revision tag (Revision: v3.4.0) along with updated QC criteria text and a No FEAR Act Data notice.SummaryDifference0.3%

- Check61 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. This appears to be a metadata update rather than a modification of study content.SummaryDifference0.1%

- Check89 days agoChange DetectedA new Locations section is added, listing Illinois and Tennessee study sites (Illinois and Tennessee), consolidating location details.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab for Advanced Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page.